Data Standards in the Drug Lifecycle

Having standard, uniform study data enables FDA scientists to explore many new questions by combining data from multiple studies. Data standards also help FDA receive, process, review, and archive submissions more efficiently and effectively.

CDER and CBER receive many kinds of data. Data standards enable FDA to modernize and streamline the review process.

Interactive “Data Standards in the Drug Lifecycle” Infographic

Click through this interactive infographic to get information about the data standards and their role in the drug lifecycle.

Click through the interactive “Data Standards in the Drug Lifecycle” Infographic

Page Last Updated: 01/24/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English